img
img
Do peripheral melatonin agonists improve bone fracture healing? The effects of agomelatine and ramelteon on experimental bone fracture    
Yazarlar (7)
Duygu Köse
Atatürk Üniversitesi, Türkiye
Ahmet Köse
Türkiye
Zekai Halıcı
Atatürk Üniversitesi, Türkiye
Muhammet Ali Gürbüz
Atatürk Üniversitesi, Türkiye
Ali Aydın
Atatürk Üniversitesi, Türkiye
Rüstem Anıl Uğan
Atatürk Üniversitesi, Türkiye
Doç. Dr. Erdem TOKTAY Doç. Dr. Erdem TOKTAY
Kafkas Üniversitesi, Türkiye
Devamını Göster
Özet
Melatonin improves fracture healing, but the long-term use of melatonin seems impracticable in the treatment of fracture due to side effects caused by hormonal stress on chronological rhythm. Ramelteon (RAMEL) and agomelatine (AGO) are non-selective peripheral melatonin receptor (MT) agonists. This study investigated the effects on bone fracture healing of these MT agonists, which do not affect the central nervous system. The rats were divided into 6 groups, including Group 1 (SHAM): sham operated group; Group 2 (FRACTURE): femoral fracture control; Group 3 (FR + AGO30): femoral fracture + agomelatine 30 mg/kg; Group 4 (FR + AGO60): femoral fracture + agomelatine 60 mg/kg; Group 5 (FR + RAMEL3): femoral fracture + ramelteon 3 mg/kg; and Group 6 (FR + RAMEL6): femoral fracture + ramelteon 6 mg/kg. After 21 days, the rats were subjected to X-ray imaging. Bone healing was evaluated with hematoxylin-eosin (HE) staining. Messenger RNA (mRNA) expressions of bone formation markers, such as bone alkaline phosphatase (ALP), osteocalcin (OC), and osteopontin (OP), were evaluated by real-time polymerase chain reaction (RT-PCR) and with immunohistochemistry (IHC) staining. The radiographic fracture healing scores were statistically significantly higher in the FR + AGO60 group and the FR + RAMEL3 group than in the FRACTURE group. The histopathology and molecular results supported the radiographic results. It was shown that agomelatine and ramelteon increase bone fracture healing, leading to the conclusion that a preference for agomelatine, an antidepressant, and ramelteon, a sleep aid, will increase bone fracture healing in patients with fractures.
Anahtar Kelimeler
Agomelatine | Fracture healing | Melatonine | Ramelteon
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı European Journal of Pharmacology
Dergi ISSN 0014-2999 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q2
Makale Dili İngilizce
Basım Tarihi 11-2020
Cilt No 887
Sayfalar 173577 /
Makale Linki https://linkinghub.elsevier.com/retrieve/pii/S0014299920306695
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları

Paylaş